Log In
BCIQ
Print this Print this
 

GEA009.2

  Manage Alerts
Collapse Summary General Information
Company GenOdyssee S.A.
DescriptionAntiviral interferon (IFN) alpha 21 variant
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today